Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells

Molecular Pharmacology

Volumn 70, Issue 4, 2006, Pages 1443-1453

  Yeh, Chun Wei ^a   Huang, Sheng Shun ^a   Lee, Ru Ping ^a   Yung, Benjamin Yat Ming ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MYC PROTEIN; NUCLEOPHOSMIN; RAS PROTEIN;

ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE ACTIVITY; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; UPREGULATION;

BASE SEQUENCE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; ONCOGENE PROTEIN P21(RAS); PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; TRANS-ACTIVATION (GENETICS); TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 33748935161     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.024810     Document Type: Article

References (43)

1. Adachi Y, Copeland TD, Hatanaka M, and Oroszlan S (1993) Nucleolar targeting signal of Rex protein of human T-cell leukemia virus type I specifically binds to nucleolar shuttle protein B23. J Biol Chem 268:13930-13934.
2. Bernhard W and Granboulan N (1968) Electron microscopy of the nucleolus in vertebrate cells, in Ultrastructure in Biological Systems: The Nucleus (Dalton AJ and Haguenau F eds) vol 3, pp 81-149, Academic Press, New York.
3. Borer RA, Lehner CF, Eppenberger HM, and Nig EA (1989) Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56:379-390.
4. Busch H, Byvoet P, and Smetana K (1963) The nucleolus of the cancer cell: a review. Cancer Res 23:313-339.
5. Chan HJ, Weng JJ, and Yung BYM (2005) Nucleophosmin/B23-binding peptide inhibits tumor growth and up-regulates transcriptional activity of p53. Biochem Biophys Res Commun 333:396-403.
6. Chan WY, Liu QR, Borjigin J, Busch H, Rennert OM, Tease TM, and Chan PK (1989) Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28:1033-1039.
7. Cole MD (1986) The myc oncogene: its role in transformation and differentiation. Annu Rev Genet 20:361-384.
8. Arf protein stability. Mol Cell Biol 20:8874-8886.
9. Colombo E, Marine JC, Danovi D, Falini B, and Pelicci PG (2002) Nucleophosmin/B23 regulates the stability and transcriptional activity of p53. Nat Cell Biol 4:529-533.
10. Crews CM and Erikson RL (1993) Extracellular signals and reversible protein phosphorylation: what to MEK of it all. Cell 74:215-217.
11. Fankhauser C, Izaurralde E, Adachi Y, Wingfield P, and Laemmli UK (1991) Specific complex of human immunodeficiency virus type 1 Rev and nucleolar B23 proteins: dissociation by the Rev response element. Mol Cell Biol 11:2567-2575.
12. Feuerstein N, Spiegel S, and Mond JJ (1988) The nuclear matrix protein, numatrin (B23), is associated with growth factor-induced mitogenesis in Swiss 3T3 fibroblasts and with T lymphocyte proliferation stimulated by lectins and anti-T cell antigen receptor antibody. J Cell Biol 107:1629-1642.
13. Foresman WH and Messing EM (1997) Bladder cancer: natural history, tumor markers and early detection strategies. Semin Surg Oncol 12:299-306.
14. Gnomom PE, Rudely A, Jason C, Lording G, Thomas SJ, Brandvold KA, Lee R, Burnside J, and Delrow J (2001) Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius. Proc Natl Acad Sci USA 98:6378-6383.
15. Guo QM, Malek RL, Kim S, Chiao C, He M, Ruffy M, Sanka K, Lee NH, Dang CV, and Liu ET (2000) Identification of c-myc responsive genes using rat cDNA microarray. Cancer Res 60:5922-5928.
16. Hsu ZY and Yung BYM (1998) Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells. Oncogene 16:915-923.
17. Inouye CJ and Seto E (1994) Relief of YY1-induced transcriptional repression by protein-protein interaction with the nucleolar phosphoprotein B23. J Biol Chem 269:6506-6510.
18. Johnson FB, Marciniak RA, and Guarente L (1998) Telomerase, the nucleolus and aging. Curr Opin Cell Biol 10:332-338.
19. Kato T, Ishikawa K, Nemoto R, Senoo A, and Amano Y (1978) Morphological characterization of two established cell lines, T-24 and MGH-U1, derived from human urinary bladder carcinoma. Tohoku J Exp Med 124:339-349.
20. Kim S, Li QL, Dang CV, and Lee LA (2000) Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-myc in vivo. Proc Natl Acad Sci USA 97:11198-11202.
21. Kondo T, Minamino N, Nagamura-Inoue T, Matsumoto M, and Taniguchi T (1997) Identification and characterization of nucleophosmin/B23 / numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene 15:1275-1281.
22. Konetry BR and Getzenberg RH (2001) Urine based markers of urological malignancy. J Urol 165:600-611.
23. Kurki S, Peltonen K, Latonen L, Kiviharju TM, Ojala PM, Meek D, and Laiho M (2004) Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 5:465-475.
24. Li J, Zhang X, Sejas DP, Bagby GC, and Pang Q (2004) Hypoxia-induced nucleophosmin/B23 protects cell death through inhibition of p53. J Biol Chem 279:41275-41279.
25. Lin CW, Lin JC, and Prout GR Jr (1985) Establishment and characterization of four human bladder tumor cell lines and sublines with different degrees of malignancy. Cancer Res 45:5070-5079.
26. Liu WH and Yung BYM (1998) Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23. Oncogene 17:3055-3064.
27. Mai RT, Yeh TS, Kao CF, Sun SK, Huang HH, and Lee YHW (2005) Hepatitis C virus core protein recruits nucleolar phosphoprotein B23 and coactivator p300 to relieve the repression effect of transcriptional factor YY1 on B23 gene expression. Oncogene 1-15.
28. Maiguel DA, Jones L, Chakravarty D, Yang C, and Carrier F (2004) Nucleophosmin/B23 sets a threshold for p53 response to UV radiation. Mol Cell Biol 24:3703-3711.
29. Mccormick F (1994) Activators and effectors of ras p21 proteins. Curr Opin Genet Dev 4:71-76.
30. Mulcahy IS, Smith MR, and Stacey DW (1985) Requirement for ras proto-oncogene function during serum-stimulated growth of NIH-3T3 cells. Nature (Lond) 313:241-243.
31. Neiman PE, Ruddell A, Jasoni C, Loring G, Thomas SJ, Bransvold KA, Lee R, Burnside J, and Delrow J (2001) Analysis of gene expression during myc oncogeneinduced lymphomagenesis in the bursa of fabricius. Proc Natl Acad Sci USA 98:6378-6383.
32. Nesbit CE, Tersak JM, and Prochownik EV (1999) Myc oncogenes and human neoplastic disease. Oncogene 18:3004-3016.
33. Newling DW (1996) Preventing recurrence and progression in superficial bladder cancer. Curr Opin Urol 6:272-279.
34. Pederson T (1998) The plutifunctional nucleolus. Nucleic Acid Res 26:3871-3877.
35. Raghaven D, Shipley WU, Garnick MB, Rusell PJ, and Richie JP (1990) Biology and management of bladder cancer. N Engl J Med 322:1129-1138.
36. Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridlev A, and Downward J (1997) Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457-467.
37. Sears R, Leone G, DeGregori J, and Nevins JR (1999) Ras enhances Myc protein stability. Mol Cell 3:169-179.
38. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, and Nevins JR (2000) Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 14:2501-2514.
39. Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, and Matsuyama T (1994) Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77:829-839.
40. Tsui KH, Cheng AJ, Chang PL, Pan TL, and Yung BYM (2004) Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Urology 64:839-844.
41. Valdez BC, Perlaky L, Henning D, Saijo Y, Chan PK, and Busch H (1994) Identification of the nuclear and nucleolar localization signals of the protein p120: interaction with translocation protein B23. J Biol Chem 269:23776-23783.
42. You BJ, Huang IJ, Liu WH, Hung YB, Chang JH, and Yung BY (1999) Decrease in nucleophosmin/B23 mRNA and telomerase activity during indomethacin-induced apoptosis of gastric KATO-III cancer cells. Naunyn-Schmiedeberg's Arch Pharmacol 360:683-690.
43. Zeller KI, Haggerty TJ, Barret JF, Guo Q, Wonsey DR, and Dang CV (2001) Characterization of nucleophosmin (B23) as a myc target by scanning chromatin immunoprecipitation. J Biol Chem 276:48285-48291.